As age advances, subclinical hypothyroidism (SCH) is known to rapidly advance touching more on women as compared to men as the elderly being rated more vulnerable. SCH also known as mild hypothyroidism has been defined by scientists as a superior case of the thyroid stimulating hormone TSH levels with free thyroxine concentrations with the reference range (Baumgartner, 2014).
The condition; SCH, can be successfully identified through comprehensive thyroid tests for nonspecific indicators some of them being fatigue, weight gain, depression and any other necessary. Due to the unspecific nature of the symptoms, FNP is befallen with a responsibility of identifying the core cause of the signs whether a relative deficiency in thyroid hormone triggered it. Furthermore, concrete data and confirmation should be the sort to approve if thyroxine replacement would provide a solution for the patient before administering (Baumgartner, 2014). …show more content…
However, there has been a great clinical conflict over the past two decades in diagnosing the signs and inspecting the TSH levels to enable treat SCH. According to (Rodondi, 2013), SCH is an area so far that hasn't been resolved with no relevant clinical outcomes having been researched (Gussekloo, 2014). Having no defined boundaries in this area, the FNP inherits an important role in forming the implications of diagnosis, which are uncertain and bringing out the level of relevance of L-thyroxine therapy.
Statement of Clinical Question
How relevant and effective is the levothyroxine treatment over subclinical hypothyroidism among adults and most especially the elderly patients? This research aims at settling and providing adequate response to this question beyond any doubt.
Presentation of
The condition; SCH, can be successfully identified through comprehensive thyroid tests for nonspecific indicators some of them being fatigue, weight gain, depression and any other necessary. Due to the unspecific nature of the symptoms, FNP is befallen with a responsibility of identifying the core cause of the signs whether a relative deficiency in thyroid hormone triggered it. Furthermore, concrete data and confirmation should be the sort to approve if thyroxine replacement would provide a solution for the patient before administering (Baumgartner, 2014). …show more content…
However, there has been a great clinical conflict over the past two decades in diagnosing the signs and inspecting the TSH levels to enable treat SCH. According to (Rodondi, 2013), SCH is an area so far that hasn't been resolved with no relevant clinical outcomes having been researched (Gussekloo, 2014). Having no defined boundaries in this area, the FNP inherits an important role in forming the implications of diagnosis, which are uncertain and bringing out the level of relevance of L-thyroxine therapy.
Statement of Clinical Question
How relevant and effective is the levothyroxine treatment over subclinical hypothyroidism among adults and most especially the elderly patients? This research aims at settling and providing adequate response to this question beyond any doubt.
Presentation of